Societ
Beyond's analysis on Societ
Recent news mentioning Societ
- — Mineralys Therapeutics Announces Presentation of New Lorundrostat Data at the American Society of Nephrology (ASN) Kidney Week 2026
- — BioMarin Announces Five-Year Phase 3 Data for POMBILITI® (cipaglucosidase alfa-atga) + OPFOLDA® (miglustat) at World Muscle Society Annual Congress
- — Climb Bio to Present New Data at American Society of Nephrology (ASN) Kidney Week 2026 for CLYM116 and Budoprutug
- — ProKidney Announces Eight Abstracts Selected for Presentation at the American Society of Nephrology’s Kidney Week 2026
- — Immuneering to Present at the 41st Annual Meeting of the Society for Immunotherapy of Cancer (SITC)
- — R. Jude Samulski Receives Inaugural Founders Award from Chinese Society of Gene & Cell Therapy
- — Atletica paralimpica, a Jesolo la finale nazionale dei Campionati Italiani di Società
- — "Energy Superpower" Canada may be Hampered by Climate-addled Central Bankers says Friends of Science Society
- — Societe Generale: Completion of the EUR 1.5 billion extraordinary share buy-back programme for cancellation purpose
- — Societe Generale: shares and voting rights as of 23 September 2026
- — Brogidirsen (NS-089/NCNP-02) 5-Year Clinical Trial Data for the Treatment of Duchenne Muscular Dystrophy Presented at 2026 World Muscle Society Congress
- — New Canaan Society Expands National Board, Adding Five New Directors to Strengthen Generational Diversity and Scale as Growth Accelerates